References
- Dispenzieri A. POEMS syndrome. Blood Rev 2007;21:285–299.
- Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347:702.
- Kaushik M, Pulido JS, Abreu R, Amselem L, Dispenzieri A. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. Ophthalmology 2011;118:778–782.
- Menke MN, Feke GT, Trempe CL. OCT measurements in patients with optic disc edema. Invest Ophthalmol Vis Sci 2005;46:3807–3811.
- Skau M, Milea D, Sander B, Wegener M, Jensen R. OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol 2011;249:723–730.
- Yokouchi H, Baba T, Misawa S, Sawai S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol 2015;100:897–901.
- Doi S, Kimura S, Morizane Y, Hosogi M, Hosokawa M, Shiode Y, Kawata T, Kondo E, Shiraga F. POEMS syndrome in a 20-year-old patient diagnosed following a complaint of reduced visual acuity. Acta Med Okayama 2014;68:379–383.
- Yokouchi H, Oshitari T, Baba T, Yamamoto S. Thalidomide reduces choroidal thickness and optic disc edema in a patient with POEMS syndrome. Graefes Arch Clin Exp Ophthalmol 2015;253:1195–1198.
- Ecsedy M, Schneider M, Nemes J, Nemeth J, Recsan Z. Optical coherence tomography features of POEMS syndrome and Castleman disease-associated papillopathy. Ocul Immunol Inflamm 2014;22:454–460.
- Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol 2014;89:214–223.
- Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, Watanabe O, Takashima H, Nishizawa M, Kawachi I, Kusunoki S, Mitsui Y, Kikuchi S, Nakashima I, Ikeda S I, Kohara N, Kanda T, Kira JI, Hanaoka H, Kuwabara S. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2016;15:1129–1137.
- Blade J, Cibeira MT, Rosinol L. Bortezomib: a valuable new antineoplastic strategy in multiple myeloma. Acta Oncol 2005;44:440–448.
- Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M. Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol 2010;84:175–177.
- Kuwabara S, Misawa S, Kanai K, Kikkawa Y, Nishimura M, Nakaseko C, Cho RK, Hattori T. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006;66:105–107.
- Park B, Yoo KH, Kim C. Hematopoietic stem cell expansion and generation: the ways to make a breakthrough. Blood Res 2015;50:194–203.
- Yokouchi H, Baba T, Misawa S, Sawai S, Beppu M, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome. Graefes Arch Clin Exp Ophthalmol 2015;253:1641–1646.
- Yokouchi H, Baba T, Misawa S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol 2016 Oct 4. pii: bjophthalmol-2016-309319.
- Hudson N, Powner MB, Sarker MH, Burgoyne T, Campbell M, Ockrim ZK, Martinelli R, Futter CE, Grant MB, Fraser PA, Shima DT, Greenwood J, Turowski P. Differential apicobasal VEGF signaling at vascular blood-neural barriers. Dev Cell 2014;30:541–552.
- Tso MO, Shih CY, McLean IW. Is there a blood-brain barrier at the optic nerve head? Arch Ophthalmol 1975;93:815–825.
- Song HB, Yu HG. Optic disc edema responding to localized anti-vascular endothelial growth factor treatment in a patient with POEMS syndrome. Korean J Ophthalmol 2015;29:357–358.
- Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, Nomura F, Shibuya K, Sekiguchi Y, Iwai Y, Watanabe K, Amino H, Ohwada C, Takeuchi M, Sakaida E, Nakaseko C, Kuwabara S. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open 2015;5:e009157.